RASPOHERB COMBINATION PRODUCT SYRUP

Indications

• Cough
• Bronchitis
• Asthma
• Respiratory tract infections
• Inflammatory conditions

Dosage

Children: Refer to established guidelines or consult a healthcare professional for appropriate dosing.

Adults: Refer to established guidelines or consult a healthcare professional for appropriate dosing.

Mechanism of action

The primary active components of Adhatoda, particularly vasicine and vasicinone, exhibit bronchodilator effects by relaxing the bronchial smooth muscles. They also act as mucolytics, facilitating the clearance of mucus from the respiratory tract. Furthermore, these compounds have been shown to exert anti-inflammatory effects by inhibiting the release of pro-inflammatory cytokines and mediators. This multi-faceted mechanism makes Adhatoda effective in alleviating symptoms associated with respiratory ailments.

Pharmacodynamics

Adhatoda demonstrates a range of pharmacodynamic effects, including bronchodilation, mucus secretion modulation, and anti-inflammatory action. The alkaloids enhance ciliary action in the respiratory tract, improving mucus clearance. The anti-inflammatory properties reduce airway inflammation, which is beneficial in conditions such as asthma and chronic bronchitis. Additionally, the antimicrobial activity of Adhatoda may help in preventing secondary infections in respiratory diseases.

Pharmacokinetics

The pharmacokinetics of Adhatoda have not been extensively studied. However, it is known that the active compounds are absorbed after oral administration, with effects typically observed within hours. The metabolic pathways of vasicine and other alkaloids involve hepatic metabolism, and they are likely excreted in urine. The bioavailability and half-life of these compounds require further investigation to establish precise pharmacokinetic profiles.

Adverse effects

• Nausea
• Vomiting
• Diarrhea
• Dizziness
• Headache
• Skin rash

Interactions

• May interact with anticoagulants, increasing the risk of bleeding
• Potential interaction with antihypertensive medications

Precautions

• Use with caution in patients with a history of gastrointestinal disorders
• Should be used cautiously in patients with liver disease
• Monitor for potential allergic reactions

Pregnancy

Ahdatoda should be used cautiously during pregnancy. Consultation with a healthcare provider is recommended.

Breast-feeding

Safety during breastfeeding has not been established; consult a healthcare provider.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Formulations

• Dried leaves
• Powdered form
• Extracts

Indications

• Stress relief
• Anxiety management
• Cognitive enhancement
• Improvement of physical performance
• Support for immune function

Dosage

Children: Refer to established herbal guidelines or consult with a healthcare provider for appropriate dosing.

Adults: Refer to established herbal guidelines or consult with a healthcare provider for appropriate dosing.

Mechanism of action

The primary active compounds in Cordifolia are known as withanolides, which exhibit a variety of pharmacological effects. These compounds modulate several signaling pathways, including the inhibition of the nuclear factor kappa B (NF-kB) and the activation of the AMP-activated protein kinase (AMPK). This modulation leads to anti-inflammatory, antioxidant, and neuroprotective effects. Additionally, withanolides may influence neurotransmitter levels, thereby aiding in mood regulation and cognitive enhancement.

Pharmacodynamics

Cordifolia demonstrates adaptogenic effects, helping the body resist stressors of various kinds. It has been shown to improve physical endurance, enhance memory and cognitive function, and exert a calming effect on the nervous system. The herb also exhibits immunomodulatory properties, promoting a healthy immune response while reducing inflammation.

Pharmacokinetics

The pharmacokinetics of Cordifolia are not extensively studied compared to conventional pharmaceuticals. However, it is generally understood that withanolides are absorbed in the gastrointestinal tract, undergo hepatic metabolism, and are excreted primarily through urine and feces. The bioavailability of these compounds can be affected by various factors, including formulation and dosage form.

Pregnancy

Insufficient data available; consult healthcare provider.

Breast-feeding

Insufficient data available; consult healthcare provider.

Storage

Store in a cool, dry place away from direct sunlight.

Indications

• Inflammatory conditions
• Cancer prevention and treatment
• Antioxidant therapy
• Digestive disorders
• Cardiovascular health

Dosage

Children: Refer to the BNF for Children for appropriate pediatric dosing recommendations.

Adults: Refer to the BNF for specific dosing guidelines, as dosages can vary based on the formulation and clinical indication.

Mechanism of action

Curcumin acts as a scavenger of reactive oxygen species, including hydroxyl radicals and superoxide anions, and inhibits lipid peroxidation as well as peroxide-induced DNA damage. It exhibits potent anti-inflammatory and anti-carcinogenic effects by modulating various signaling molecules. Curcumin inhibits protein kinases, c-Jun/AP-1 activation, and cyclooxygenase (COX)-2 activity, impacting cellular signal transduction pathways related to growth and malignant transformation.

Pharmacodynamics

In experimental animal models, curcumin has demonstrated significant pharmacological effects, such as increasing bile flow and inhibiting inflammation and edema formation. It has been shown to decrease cell proliferation and promote apoptosis in cancer cells. Additionally, curcumin inhibits platelet aggregation induced by arachidonic acid, suggesting its role in cardiovascular health.

Pharmacokinetics

Curcumin's pharmacokinetics are characterized by low bioavailability due to rapid metabolism and systemic elimination. It undergoes extensive hepatic metabolism, leading to the production of several metabolites. The absorption of curcumin can be enhanced by co-administration with piperine. Oral bioavailability remains a challenge, which has led to the exploration of various formulations to improve its therapeutic efficacy.

Adverse effects

• Gastrointestinal disturbances
• Nausea
• Diarrhea
• Allergic reactions

Interactions

• May enhance the effects of anticoagulants
• Potential interaction with antidiabetic medications
• May interfere with the metabolism of certain drugs due to inhibition of cytochrome P450 enzymes

Precautions

• Use with caution in patients with gallbladder disease
• Monitor patients on anticoagulant therapy
• Caution in patients with diabetes due to potential hypoglycemic effects

Pregnancy

Safety during pregnancy has not been established, caution is advised.

Breast-feeding

Curcumin may be excreted in breast milk, caution is advised.

Storage

Store in a cool, dry place away from light.

Formulations

• Powder
• Capsules
• Tablets
• Liquid extracts

Indications

• Asthma
• Bronchitis
• Respiratory distress
• Hypotension
• Weight loss

Dosage

Children: Refer to established dosing guidelines, as specific dosing for paediatric patients should be determined based on age, weight, and clinical condition.

Adults: Refer to established dosing guidelines, as specific dosing can vary based on the formulation and indication.

Mechanism of action

Ephedra primarily acts as an adrenergic agonist, stimulating alpha and beta-adrenergic receptors. This action leads to bronchodilation, increased heart rate, and enhanced release of norepinephrine, contributing to its stimulant effects. The compounds in Ephedra can also promote thermogenesis and fat oxidation, making it popular in weight loss supplements.

Pharmacodynamics

The stimulant effects of ephedra are mediated through its action on the central nervous system and cardiovascular system. It increases heart rate and blood pressure by enhancing catecholamine release, which can lead to increased energy expenditure and alertness. The bronchodilator effect is beneficial in alleviating symptoms of bronchospasm. However, the use of ephedra is associated with several side effects, including hypertension, palpitations, and anxiety.

Pharmacokinetics

Ephedra alkaloids are well absorbed from the gastrointestinal tract. They have a relatively short half-life, typically ranging from 3 to 6 hours, depending on the individual and the specific compound. The metabolism of ephedrine occurs primarily in the liver, and elimination is mainly via renal excretion. The pharmacokinetic profile varies based on factors such as dosage, formulation, and patient characteristics.

Contra-indications

• Severe hypertension
• Cardiovascular disease
• Hyperthyroidism
• Glaucoma
• Pregnancy
• Lactation
• History of stroke or seizure disorders

Adverse effects

• Increased heart rate
• Increased blood pressure
• Nervousness
• Insomnia
• Dizziness
• Headache
• Gastrointestinal disturbances
• Dry mouth

Interactions

• Monoamine oxidase inhibitors (MAOIs)
• Stimulants
• Antihypertensive agents
• Beta-agonists
• Caffeine

Precautions

• Use caution in patients with a history of anxiety disorders
• Monitor blood pressure and heart rate regularly
• Use with caution in patients with diabetes
• Consider potential for abuse and dependence

Pregnancy

Use of ephedra during pregnancy is contraindicated due to potential risks to the fetus, including congenital anomalies and low birth weight.

Breast-feeding

Ephedra is generally not recommended during breastfeeding as it may pass into breast milk and affect the infant.

Storage

Store in a cool, dry place away from light. Keep out of reach of children.

Formulations

• Tablets
• Capsules
• Powder
• Liquid extracts

Indications

• Gastrointestinal disorders (e.g., peptic ulcers, dyspepsia)
• Respiratory conditions (e.g., cough, bronchitis)
• Inflammatory conditions (e.g., arthritis, dermatitis)
• Viral infections (e.g., hepatitis, herpes simplex)

Dosage

Children: Refer to established clinical guidelines for appropriate dosing, as no specific dose is provided.

Adults: Refer to established clinical guidelines for appropriate dosing, as no specific dose is provided.

Mechanism of action

Glycyrrhizin, the active compound in glabra, inhibits the enzyme 11β-hydroxysteroid dehydrogenase type 2, leading to increased cortisol levels in tissues. This mechanism helps to reduce inflammation and modulate immune responses. Additionally, glabra exhibits antiviral activity by inhibiting the replication of certain viruses, possibly through interference with viral proteins and host cell interactions.

Pharmacodynamics

The pharmacodynamic effects of glabra are primarily attributed to glycyrrhizin and flavonoids present in the plant. Its anti-inflammatory effects are mediated through the inhibition of pro-inflammatory cytokines and pathways such as NF-κB. The compound also has expectorant properties, aiding in the relief of cough and respiratory distress by promoting mucus secretion and reducing irritation in the airways.

Pharmacokinetics

Glycyrrhizin is absorbed in the gastrointestinal tract, and its bioavailability can be influenced by the presence of other food components. Once absorbed, it undergoes hepatic metabolism, with its metabolites excreted primarily through urine. The half-life of glycyrrhizin can vary but is generally several hours, necessitating multiple doses for sustained therapeutic effects. Chronic use may lead to accumulation and potential side effects such as hypertension and hypokalemia due to its mineralocorticoid-like effects.

Pregnancy

The safety of glabra during pregnancy has not been established. It is advisable to avoid its use unless clearly needed.

Breast-feeding

There is limited information on the excretion of glabra in human milk. Caution is advised when administering to breastfeeding mothers.

Storage

Store at room temperature, away from moisture and direct light. Keep out of reach of children.

Indications

• Gastrointestinal disorders
• Sore throat
• Cough
• Adjuvant therapy for viral infections
• Chronic fatigue syndrome
• Adrenal insufficiency

Dosage

Children: Refer to established guidelines and clinical protocols for specific dosing recommendations.

Adults: Refer to established guidelines and clinical protocols for specific dosing recommendations.

Mechanism of action

Glycyrrhizin, the active compound in glycyrrhiza, inhibits the enzyme 11-beta-hydroxysteroid dehydrogenase type 2, which leads to increased levels of cortisol. This mechanism results in a pseudohyperaldosteronism effect, enhancing sodium retention and potassium excretion. Furthermore, glycyrrhiza exhibits anti-inflammatory effects through inhibition of the production of inflammatory cytokines and modulation of immune response pathways.

Pharmacodynamics

Glycyrrhiza has a variety of pharmacological effects, including anti-inflammatory, immunomodulatory, and antiviral properties. It has been shown to enhance mucosal defense mechanisms, making it beneficial in gastrointestinal disorders. Its immunomodulatory effects may be attributed to its ability to influence the activity of various immune cells, including macrophages and lymphocytes.

Pharmacokinetics

Glycyrrhizin is primarily absorbed in the gastrointestinal tract, with peak plasma concentrations occurring within a few hours after ingestion. It undergoes extensive metabolism in the liver, where it is converted into various metabolites. It has a relatively long half-life, allowing for sustained effects. The elimination is primarily renal, with metabolites excreted in the urine. The pharmacokinetics can be influenced by factors such as age, liver function, and co-administration of other medications.

Contra-indications

• Hypersensitivity to glycyrrhiza or any of its components
• Severe renal impairment
• Hypertension
• Hypokalemia
• Corticosteroid therapy

Adverse effects

• Hypertension
• Hypokalemia
• Edema
• Headache
• Fatigue
• Gastrointestinal disturbances
• Muscle weakness
• Heart rhythm disturbances

Interactions

• Corticosteroids - may enhance the effects of corticosteroids
• Diuretics - glycyrrhiza may counteract the effects of potassium-sparing diuretics
• Antihypertensives - may reduce the efficacy of antihypertensive medications
• Cardiac glycosides - may increase the risk of arrhythmias due to hypokalemia

Precautions

• Use with caution in patients with cardiovascular disease
• Monitor blood pressure and potassium levels during prolonged use
• Avoid excessive doses to prevent serious side effects
• Consult healthcare professionals before use in pregnant or breastfeeding women

Pregnancy

Glycyrrhiza should be used with caution during pregnancy, as excessive consumption may be linked to risks such as preterm labor or fetal harm.

Breast-feeding

Limited data on the safety of glycyrrhiza during breastfeeding; consult a healthcare professional before use.

Storage

Store in a cool, dry place, away from direct sunlight. Keep out of reach of children.

Formulations

• Dried root
• Powdered extract
• Tincture
• Syrup
• Capsules

Indications

• Anxiety
• Insomnia
• Nutritional supplement
• Antioxidant support
• Immune system support

Dosage

Children: Refer to authoritative sources for specific dosing information.

Adults: Refer to authoritative sources for specific dosing information.

Mechanism of action

The mechanism of action of Longan is not fully elucidated, but it is believed to exert its effects through the modulation of neurotransmitters, particularly influencing serotonin and gamma-aminobutyric acid (GABA) pathways. The fruit is rich in antioxidants, which may contribute to its protective effects against oxidative stress.

Pharmacodynamics

Longan is known for its high content of vitamins, minerals, and antioxidants, including vitamin C, B vitamins, and polyphenols. These compounds may enhance immune function, promote nervous system health, and improve skin health. Its calming effects may be attributed to constituents that influence neurotransmitter activity.

Pharmacokinetics

The pharmacokinetics of Longan is not well-studied, but as a food source, it is likely to be absorbed through the gastrointestinal tract. The bioavailability of its active compounds may vary depending on preparation methods (fresh, dried, or processed). The metabolism and excretion pathways are not clearly defined in the literature.

Pregnancy

Insufficient data on the safety of longa during pregnancy. Consult a healthcare provider before use.

Breast-feeding

Insufficient data on the excretion of longa in human milk. Caution is advised when using during breastfeeding.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Indications

• Irritable bowel syndrome (IBS)
• Diarrhea
• Constipation
• Gut dysbiosis
• Support for immune function
• Enhancement of gut health

Dosage

Adults: Refer to specific product guidelines and consult a healthcare professional for dosing recommendations, as doses can vary based on formulation and intended

Mechanism of action

Bifidobacterium longum exerts its beneficial effects primarily through the modulation of the gut microbiota. It helps in the fermentation of dietary fibers, producing short-chain fatty acids (SCFAs) that nourish colon cells and maintain gut barrier integrity. Moreover, it competes for adhesion sites and nutrients against pathogenic bacteria, thereby inhibiting their growth. This strain also has immunomodulatory effects, enhancing the host's immune response by promoting the production of anti-inflammatory cytokines and increasing the activity of immune cells.

Pharmacodynamics

The pharmacodynamics of Bifidobacterium longum involve its ability to balance the gut microbiome, enhance mucosal immunity, and improve intestinal permeability. It has been shown to lower the pH of the gut, creating an unfavorable environment for pathogenic organisms. Additionally, it can alleviate symptoms associated with gastrointestinal disorders such as irritable bowel syndrome (IBS), diarrhea, and constipation by promoting regular bowel movements and reducing inflammation in the gut.

Pharmacokinetics

Bifidobacterium longum is not absorbed into the systemic circulation but acts locally within the gastrointestinal tract. Its effects are primarily exerted in the intestines, where it colonizes and interacts with the gut environment. The survival and efficacy of this probiotic can be influenced by factors such as the formulation, dosage, and the individual's existing gut microbiota. Generally, ingestion of probiotics leads to transient colonization, with the bacteria being excreted in feces within a few days after discontinuation of use.

Pregnancy

Safety during pregnancy has not been established. Consult healthcare professionals before use.

Breast-feeding

Safety during breastfeeding has not been established. Consult healthcare professionals before use.

Storage

Store in a cool, dry place, away from direct sunlight and moisture.

Indications

• Nutritional supplement
• Antioxidant support
• Anti-inflammatory agent
• Management of diabetes
• Support for cardiovascular health

Dosage

Children: Refer to product-specific recommendations and consult

Adults: Refer to product-specific recommendations and consult healthcare professionals for appropriate dosing based on individual health needs.

Mechanism of action

Moringa exhibits a variety of biological activities attributed to its phytochemical constituents, including flavonoids, polyphenols, and alkaloids. These compounds contribute to its antioxidant, anti-inflammatory, and antimicrobial properties. The mechanism of action is primarily through the modulation of oxidative stress and inflammation pathways, promoting cellular health and reducing the risk of chronic diseases. Additionally, moringa may enhance glucose metabolism and lipid profiles, supporting metabolic health.

Pharmacodynamics

The pharmacodynamic effects of moringa involve the interaction of its active compounds with various cellular pathways. The antioxidants in moringa scavenge free radicals, reducing oxidative stress in the body. Its anti-inflammatory effects are mediated through the inhibition of pro-inflammatory cytokines and enzymes, which helps in managing inflammation-related conditions. Moringa has also been shown to improve insulin sensitivity and glycemic control, making it beneficial for individuals with diabetes. Furthermore, some studies suggest potential antihypertensive effects, contributing to cardiovascular health.

Pharmacokinetics

The pharmacokinetic properties of moringa are not extensively studied, but it is believed that its active constituents are absorbed in the gastrointestinal tract after consumption. The bioavailability of these compounds can be influenced by various factors, including the form of moringa consumed (fresh leaves, powder, or extract) and individual metabolic differences. Generally, moringa does not accumulate in the body, and its metabolites are likely excreted via urine. Further research is needed to better understand its pharmacokinetics.

Adverse effects

• Gastrointestinal disturbances
• Nausea
• Diarrhea
• Allergic reactions

Precautions

• Use cautiously in individuals with low blood pressure
• Monitor blood glucose levels in diabetic patients

Pregnancy

Moringa may have uterine-stimulating effects; consult a healthcare provider before use during pregnancy.

Breast-feeding

Moringa is generally considered safe during breastfeeding, but consult a healthcare provider for personalized advice.

Storage

Store in a cool, dry place away from direct sunlight, in a tightly sealed container.

Formulations

• Powdered leaves
• Capsules
• Tea
• Extracts

Indications

• Digestive disorders
• Respiratory conditions
• Antimicrobial therapy
• Anti-inflammatory support
• Stress relief

Dosage

Children: Refer to specific herbal preparation guidelines; there is no standard paediatric dose for Ocimum.

Adults: Refer to specific herbal preparation guidelines; there is no standard adult dose for Ocimum.

Mechanism of action

The pharmacological effects of Ocimum are primarily attributed to its essential oil constituents, such as eugenol, linalool, and other phenolic compounds. These compounds exert their effects through the modulation of various signaling pathways, including the inhibition of pro-inflammatory cytokines and the promotion of antioxidant defense mechanisms. The antimicrobial properties are believed to arise from the disruption of microbial cell membranes and interference with metabolic processes.

Pharmacodynamics

Ocimum exhibits a range of pharmacodynamic properties, including anti-inflammatory, antioxidant, and antimicrobial effects. The essential oils have been shown to reduce oxidative stress and inflammation, which can be beneficial in managing conditions related to chronic inflammation. Additionally, the herb may promote digestive health by enhancing gastrointestinal motility and reducing symptoms of dyspepsia.

Pharmacokinetics

The pharmacokinetics of Ocimum's active constituents vary, but generally, essential oils are readily absorbed through the gastrointestinal tract and metabolized in the liver. The bioavailability of these compounds can be influenced by the method of preparation (e.g., fresh, dried, or extract form) and the presence of other food components. The elimination half-life is also variable and dependent on the specific compounds involved.

Pregnancy

Limited data is available on the safety of Ocimum during pregnancy. It is advisable to use with caution and consult a healthcare provider.

Breast-feeding

Due to lack of sufficient evidence, it is recommended to consult a healthcare provider before use during breastfeeding.

Storage

Store in a cool, dry place away from direct sunlight.

Formulations

• Essential oil
• Dried leaves
• Tincture
• Powder

Indications

• Nutritional supplementation
• Management of diabetes mellitus
• Support in hyperlipidemia
• Anti-inflammatory treatment
• Antioxidant support
• Antimicrobial therapy

Dosage

Children: Refer to established guidelines or consult a healthcare professional for appropriate dosing based on the specific preparation and indication.

Adults: Refer to established guidelines or consult a healthcare professional for appropriate dosing based on the specific preparation and indication.

Mechanism of action

Moringa oleifera exhibits its pharmacological effects through various mechanisms, primarily due to its high content of bioactive compounds such as flavonoids, phenolic acids, and vitamins. These compounds have antioxidant properties that help reduce oxidative stress and inflammation in the body. Additionally, Moringa has been shown to modulate glucose metabolism, enhance lipid profiles, and exert antimicrobial effects, contributing to its use in managing diabetes, hyperlipidemia, and infections.

Pharmacodynamics

The pharmacodynamic effects of Moringa oleifera are attributed to its ability to influence key biochemical pathways. It has been found to enhance insulin sensitivity, leading to improved glucose uptake in peripheral tissues. Furthermore, its anti-inflammatory properties are linked to the inhibition of pro-inflammatory cytokines and enzymes, while its antioxidant capacity helps protect cells from oxidative damage. The plant also exhibits antimicrobial activity against a range of pathogens, supporting its traditional use in treating infections.

Pharmacokinetics

The pharmacokinetic profile of Moringa oleifera is not well-established due to limited clinical studies. However, it is known that the bioactive compounds are absorbed in the gastrointestinal tract, with peak plasma concentrations occurring after consumption. The elimination half-life and metabolism pathways of specific compounds within Moringa are still subjects of research. Factors such as preparation method (e.g., dried powder, extracts) and the presence of other food substances can influence its bioavailability.

Adverse effects

• Gastrointestinal upset
• Nausea
• Diarrhea
• Headache
• Allergic reactions

Interactions

• May interact with diabetes medications, potentially leading to hypoglycemia
• Could affect the absorption of certain medications due to its high fiber content

Precautions

• Use with caution in patients with diabetes due to potential blood sugar-lowering effects
• Consult a healthcare provider before use in pregnant or breastfeeding women
• Monitor for gastrointestinal symptoms when starting supplementation

Pregnancy

Safety during pregnancy has not been established, consult a healthcare provider before use.

Breast-feeding

Safety during breastfeeding is not well-studied, consult a healthcare provider before use.

Storage

Store in a cool, dry place, away from direct sunlight.

Formulations

• Powder
• Capsules
• Tea

Indications

• Uncomplicated malaria caused by Plasmodium falciparum

Dosage

Children: Refer to the BNF for Children for appropriate dosing in paediatric patients.

Adults: Refer to the BNF for specific dosing recommendations.

Mechanism of action

Piperaquine acts by interfering with the heme detoxification process in the malaria parasite. It accumulates within the food vacuole of the parasite and inhibits the conversion of toxic heme into non-toxic hemozoin. This accumulation of free heme leads to oxidative stress and cellular damage, ultimately resulting in the death of the parasite.

Pharmacodynamics

Piperaquine demonstrates a dose-dependent response in its antimalarial activity. It is effective against the asexual blood stages of Plasmodium species, with a prolonged half-life that allows for once-weekly dosing in some regimens. The drug's efficacy is influenced by the rate of parasite clearance and the patient's immune response.

Pharmacokinetics

Piperaquine is well-absorbed following oral administration, with peak plasma concentrations typically occurring within 4 to 6 hours. It has a long elimination half-life, which can range from 10 to 30 days, allowing for sustained plasma levels. The drug is metabolized in the liver and excreted primarily in the feces, with a smaller fraction eliminated in the urine. Its pharmacokinetics can be significantly affected by drug interactions, particularly those that alter hepatic metabolism.

Interactions

• grapefruit juice: Severe (increases concentration)
• mitotane: Severe (decreases concentration)
• St. John's wort: Severe (decreases concentration)
• rifampicin: Severe (decreases concentration)
• dronedarone: Unknown (increases concentration)
• cobicistat: Unknown (increases concentration)
• crizotinib: Unknown (increases concentration)
• idelalisib: Unknown (increases concentration)
• imatinib: Unknown (increases concentration)
• letermovir: Unknown (increases concentration)

Pregnancy

Consult with a healthcare professional regarding the use of piper during pregnancy.

Breast-feeding

Consult with a healthcare professional regarding the use of piper during breastfeeding.

Storage

Store in a cool, dry place, away from direct sunlight.

Formulations

• {'name': 'Piperaquine', 'class': 'Penicillins', 'molecular_formula': 'C38H36N4O4'}

Indications

• Anti-inflammatory conditions
• Antimicrobial applications
• Antioxidant support
• Traditional dyeing agent

Dosage

Children: Refer to established herbal dosage guidelines or consult with a healthcare professional.

Adults: Refer to established herbal dosage guidelines or consult with a healthcare professional.

Mechanism of action

The active compounds in Rubia tinctorum, particularly anthraquinones, are believed to exert their effects through several mechanisms. These include inhibition of certain enzymes, modulation of inflammatory pathways, and interaction with cellular signaling pathways. The compounds may also exhibit antioxidant properties, contributing to their therapeutic potential.

Pharmacodynamics

Rubia tinctorum has been shown to possess anti-inflammatory, antimicrobial, and antioxidant properties. The anthraquinones can influence various biological pathways, potentially leading to the modulation of immune responses and the reduction of oxidative stress in cells. Its effects may vary based on the dosage and preparation used.

Pharmacokinetics

The pharmacokinetics of Rubia tinctorum have not been extensively studied. However, it is understood that the bioavailability of its active compounds may be influenced by factors such as their solubility and stability in the gastrointestinal tract. Metabolism typically occurs in the liver, and excretion is primarily via the kidneys. Specific half-life and elimination data are not well documented.

Pregnancy

There is limited data on the safety of rubia during pregnancy. It is advisable to avoid use unless the potential benefits outweigh the risks.

Breast-feeding

The excretion of rubia in human milk is unknown. Caution is advised when used during breastfeeding.

Storage

Store in a cool, dry place, away from direct sunlight. Keep out of reach of children.

Dosage

Children: Specific dosing information for paediatric patients is not available. It is advisable to consult paediatric dosing guidelines or healthcare professionals for appropriate dosing recommendations.

Adults: Specific dosing information for adults is not available. It is recommended to refer to clinical guidelines or consult a healthcare professional for appropriate dosing recommendations.

Mechanism of action

The exact mechanism of action of Sanctum is currently unclear. However, it may involve modulation of specific biochemical pathways or receptors that influence physiological processes related to its therapeutic effects. Further studies are needed to elucidate its pharmacological properties.

Pharmacodynamics

Pharmacodynamics of Sanctum may involve interactions with cellular receptors or enzymes that lead to altered cellular functions. These interactions could affect various biological systems, potentially resulting in therapeutic outcomes. The specific pharmacodynamic profile remains to be characterized.

Pharmacokinetics

The pharmacokinetic properties of Sanctum, including absorption, distribution, metabolism, and excretion, have not been well-defined in the literature. It is essential to conduct comprehensive studies to determine how the drug behaves in the body and its potential impact on therapeutic effectiveness.

Indications

• Pain relief
• Anti-inflammatory treatment
• Antimicrobial activity
• Antioxidant support
• Potential use in neurological disorders

Dosage

Children: Refer to specific guidelines for each solanum species or preparation, as dosing can vary widely.

Adults: Refer to specific guidelines for each solanum species or preparation, as dosing can vary widely.

Mechanism of action

The mechanism of action for solanum species depends on the specific compounds present in each species. For instance, alkaloids found in some Solanum species may interact with neurotransmitter systems, potentially affecting cholinergic, dopaminergic, and serotonin pathways. Other compounds may exert antioxidant effects or influence inflammatory pathways, contributing to potential therapeutic effects.

Pharmacodynamics

The pharmacodynamics of solanum species are largely determined by their active constituents, such as alkaloids and flavonoids, which can exhibit a range of effects, including anti-inflammatory, analgesic, and antimicrobial properties. The specific effects and their intensity can vary based on the species and preparation used.

Pharmacokinetics

Pharmacokinetics of solanum compounds can vary significantly based on the specific plant species and preparation method. Generally, bioactive compounds may be absorbed through the gastrointestinal tract, metabolized in the liver, and excreted via urine or feces. The half-life and bioavailability can differ, influencing the dosing and therapeutic efficacy of the extracts.

Adverse effects

• Gastrointestinal disturbances
• Nausea
• Vomiting
• Diarrhea
• Abdominal pain
• Neurological symptoms (in cases of toxicity)

Precautions

• Use with caution in individuals with known allergies to nightshade family members
• Monitor for signs of toxicity, especially when used in higher doses
• Avoid use in children without medical supervision due to potential for adverse effects

Pregnancy

Safety during pregnancy has not been established. Use only if clearly needed and prescribed by a healthcare provider.

Breast-feeding

Caution is advised as safety during breastfeeding has not been established.

Storage

Store in a cool, dry place away from light and moisture. Keep out of reach of children.

Formulations

• Dried leaves
• Powdered extracts
• Tinctures

Indications

• Asthma
• Chronic bronchitis
• Cough
• Respiratory infections
• Lung conditions

Dosage

Children: Paediatric dosing is not specifically defined; consult relevant pediatric references or healthcare professionals for appropriate dosing.

Adults: Dosage varies based on the form of preparation and specific condition; refer to established guidelines for herbal medicines.

Mechanism of action

The active compounds in Vasaka, particularly vasicine and vasicinone, exhibit bronchodilator activity by relaxing bronchial smooth muscles. This action helps alleviate symptoms of respiratory conditions such as asthma and bronchitis. Additionally, these compounds have been shown to exert anti-inflammatory effects by inhibiting the release of pro-inflammatory mediators.

Pharmacodynamics

Vasaka has a significant impact on the respiratory system, primarily functioning as a mucolytic and bronchodilator. It facilitates the clearing of mucus from the airways, thereby improving airflow and easing breathing. The anti-inflammatory properties contribute to reducing the severity of respiratory conditions by decreasing airway inflammation.

Pharmacokinetics

The pharmacokinetics of Vasaka are not thoroughly documented in the literature. However, it is understood that the active constituents are absorbed after oral administration, with a variable bioavailability influenced by individual metabolism. The elimination half-life and specific metabolic pathways remain to be fully elucidated, necessitating further research in this area.

Adverse effects

• Gastrointestinal upset
• Nausea
• Vomiting
• Diarrhea
• Allergic reactions

Interactions

• May enhance the effects of anticoagulants
• Potential interaction with antidiabetic medications

Precautions

• Use with caution in patients with liver or kidney disease
• Monitor for signs of an allergic reaction

Pregnancy

Limited data available, consult healthcare provider before use.

Breast-feeding

Consult healthcare provider before use, as limited data is available on safety during lactation.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Formulations

• Dried leaves
• Powder
• Extracts
• Tinctures

Indications

• Skin conditions
• Inflammation
• Wound healing
• Antimicrobial use

Dosage

Children: Refer to specific guidelines or clinical studies as there is no established paediatric dosage for vulgaris.

Adults: Refer to specific guidelines or clinical studies as there is no established adult dosage for vulgaris.

Mechanism of action

The exact mechanism of action for vulgaris is not well-documented, but it is believed to involve the modulation of biochemical pathways associated with inflammation and skin health. Certain compounds may exert antioxidant effects, reduce inflammation, or promote wound healing.

Pharmacodynamics

Pharmacodynamics of vulgaris can vary based on the specific compounds present in the plant. Typically, it may influence pathways related to the immune response, skin cell proliferation, and cytokine production. Some constituents may have antimicrobial properties, which can contribute to its use in treating skin infections or irritations.

Pharmacokinetics

The pharmacokinetics of vulgaris, including absorption, distribution, metabolism, and excretion, are not well characterized in clinical studies. The bioavailability of active compounds may vary based on preparation method (e.g., topical vs oral) and individual patient factors such as metabolism and overall health.

Pregnancy

There is limited information on the safety of vulgaris in pregnancy. It is recommended to consult with a healthcare provider before use.

Breast-feeding

Information on the excretion of vulgaris in breast milk is not well established. Caution is advised while using this medication during breastfeeding.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Indications

• Anti-inflammatory conditions
• Pain management
• Fever reduction
• Antimicrobial treatment

Dosage

Children: Dosage in children should be determined by a healthcare provider, taking into consideration age, weight, and specific condition.

Adults: Dosage varies based on the formulation and condition being treated. Refer to specific herbal preparation guidelines or consult a healthcare provider.

Mechanism of action

The mechanism of action of Xanthocarpum is not fully understood, but it is believed that the active phytochemicals may exert their effects through modulation of inflammatory pathways and inhibition of cyclooxygenase and lipoxygenase enzymes. These actions can lead to a reduction in pain and inflammation, as well as possible antipyretic effects by influencing the hypothalamic heat-regulating center.

Pharmacodynamics

Xanthocarpum displays a range of pharmacodynamic effects, including anti-inflammatory and analgesic properties. The flavonoids found in the plant may have antioxidant effects, scavenging free radicals and reducing oxidative stress. Additionally, the plant may exhibit potential antimicrobial activity, contributing to its traditional use in treating infections.

Pharmacokinetics

The pharmacokinetics of Xanthocarpum are not well documented. However, it is generally understood that the absorption, distribution, metabolism, and excretion of phytochemicals can vary widely based on their chemical structures and the formulation used. Bioavailability may be influenced by factors such as the presence of other compounds in herbal preparations and individual patient characteristics.

Pregnancy

The safety of xanthocarpum during pregnancy has not been established. It is advisable to avoid use unless clearly needed.

Breast-feeding

The excretion of xanthocarpum in human milk is unknown. Caution should be exercised when administering to nursing mothers.

Storage

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Mechanism of action

Curcumin acts as a scavenger of oxygen species, such as hydroxyl radical, superoxide anion, and singlet oxygen and inhibit lipid peroxidation as well as peroxide-induced DNA damage. Curcumin mediates potent anti-inflammatory agent and anti-carcinogenic actions via modulating various signalling molecules. It suppresses a number of key elements in cellular signal transduction pathways pertinent to growth, differentiation, and malignant transformation; it was demonstrated _in vitro_ that curcumin inhibits protein kinases, c-Jun/AP-1 activation, prostaglandin biosynthesis, and the activity and expression of the enzyme cyclooxygenase (COX)-2. Curcumin, a polyphenolic natural product, exhibits therapeutic activity against a number of diseases, attributed mainly to its chemical structure and unique physical, chemical, and biological properties. It is a diferuloyl methane molecule [1,7-bis (4-hydroxy-3- methoxyphenyl)-1,6-heptadiene-3,5-dione)] containing two ferulic acid residues joined by a methylene bridge. It has three important functionalities: an aromatic o-methoxy phenolic group, alpha, beta-unsaturated beta-diketo moiety and a seven carbon linker. Extensive research in the last two decades has provided evidence for the role of these different functional groups in its crucial biological activities. A few highlights of chemical structural features associated with the biological activity of curcumin are: The o-methoxyphenol group and methylenic hydrogen are responsible for the antioxidant activity of curcumin, and curcumin donates an electron/ hydrogen atom to reactive oxygen species. Curcumin interacts with a number of biomolecules through non-covalent and covalent binding. The hydrogen bonding and hydrophobicity of curcumin, arising from the aromatic and tautomeric structures along with the flexibility of the linker group are responsible for the non-covalent interactions. The alpha, beta-unsaturated beta-diketone moiety covalently interacts with protein thiols, through Michael reaction. The beta-diketo group forms chelates with transition metals, thereby reducing the metal induced toxicity and some of the metal complexes exhibit improved antioxidant activity as enzyme mimics. New analogues with improved activity are being developed with modifications on specific functional groups of curcumin... The present study demonstrates that curcumin acts as pro-oxidant and sensitizes human lung adenocarcinoma epithelial cells (A549) to apoptosis via intracellular redox status mediated pathway. Results indicated that curcumin induced cell toxicity (light microscopy and MTT assay) and apoptosis (AnnexinV-FITC/PI labeling and caspase-3 activity) in these cells. These events seem to be mediated through generation of reactive oxygen species (ROS) and superoxide radicals (SOR) and enhanced levels of lipid peroxidation. These changes were accompanied by increase in oxidized glutathione (GSSG), reduced glutathione (GSH) and gamma-glutamylcysteine synthetase (gamma-GCS) activity, but decrease in GSH/GSSG ratio. The induction of apoptosis and decrease in GSH/GSSG ratio was also accompanied by sustained phosphorylation and activation of p38 mitogen activated protein kinase (MAPK). On the other hand, addition of N-acetyl cysteine (NAC), an antioxidant, blocked the curcumin-induced ROS production and rescued malignant cells from curcumin-induced apoptosis through caspase-3 deactivation. However, L-buthionine sulfoximine (BSO), a GSH synthesis blocking agent, further enhanced curcumin-induced ROS production and apoptosis in A549 cells. Decreased GSH/GSSG ratio seems to be a crucial factor for the activation of MAPK signaling cascade by curcumin. The study therefore, provides an insight into the molecular mechanism involved in sensitization of lung adenocarcinoma cells to apoptosis by curcumin. Curcumin has many pharmaceutical applications, many of which arise from its potent antioxidant properties. The present research examined the antioxidant activiti

Pharmacodynamics

Intravenous application of 25 mg/kg bw curcumin to rats resulted in an increase in bile flow by 80 and 120%. In the rat model of inflammation, curcumin was shown to inhibit edema formation. In nude mouse that had been injected subcutaneously with prostate cancer cells, administration of curcumin caused a marked decrease in the extent of cell proliferation, a significant increase of apoptosis and micro-vessel density. Curcumin may exert choleretic effects by increasing biliary excretion of bile salts, cholesterol, and bilirubin, as well as increasing bile solubility. Curcumin inhibited arachidonic acid-induced platelet aggregation _in vitro_.